The Queensland government has suspended puberty blockers for those under 18 due to concerns raised about state-wide paediatric gender therapies.
The recent media statement was approved by the Minister for Health and Ambulance Services, Tim Nicholls.
In the interim, the government has called for an independent review of hormone therapies and their use, which several medical professionals and psychologists working with children have been warning about for years. Nicholls has said that ‘there is contested evidence surrounding the benefits of Stage 1 and 2 hormone therapy for children and adolescents with gender dysphoria emerging from studies throughout the world’.
This raises several concerns for parents who have had their wishes suppressed under ‘conversion therapy ban’ legislation – a law that has prevented them from seeking alternative help for children confused about their gender.
The media statement from the Queensland government suggests that the medication being used to treat LGBT-identifying children may be harmful, which begs the question as to why politicians on the left approved gender conversion therapy ban laws to begin with, when the medical data on gender therapies is clearly insufficient to warrant its rollout on vulnerable and growing pubescent children.
The conversion therapy legislation has had a profound effect on professionals as many have felt pressured to ignore their gut instincts and instead prescribe drugs to children. Many health professionals were fearful of being accused of ‘discrimination’ if they tried to speak out.
The medical industry has been aware of adverse effects relating to puberty blockers, and there is a vast body of research indicating more studies need to be done to understand their long term repercussions. Some studies also suggest that there is a danger in these therapies which seek to intervene with the natural process of puberty, as artificial intervention can have devastating effects on the human brain including likely stunting otherwise important neurological development.
Imagine potentially stunting the brains of children with therapies all in the name of ‘improving mental health’. Queensland is starting to notice a serious problem, and it’s about time.
Conservatives around Australia are especially breathing a sigh of relief after a long fight to halt the prescription of gender therapies on a national scale. Australia, it seems, is finally catching up to the United Kingdom, who recently modified its laws to restrict the supply of puberty blockers to kids. It went so far as to completely ban puberty blockers for children, indefinitely, which demonstrates how dangerous UK believes they really are.
It is my view that Australia is waking up to the truth about Big Pharma’s propaganda to sell drugs to children at the expense of their fertility and other long-term problems such as permanent, irreversible physiological damage.
2025 is shaping up to be a year of change, as on January 4, the government already took a stand to prevent the expansion of the Queensland Children’s Gender Service. The WA government has also delayed putting forward any motions to pass a conversion therapy ban bill, indicating it is best to wait until after the 2025 election.
A lot is riding on the next election, including the outcome of the LGBT issue and the medications that come with it.
Queensland’s media statement that is coming before the federal election which will likely occur within the next few months, is therefore indicative of a changing opinion on the LGBT issue. The tide is certainly already turning in countries such as America, with President Trump putting an end to several DEI (diversity, equity, and inclusion) programs using an executive order.
Queensland’s independent review into the use of gender therapies will include submissions made by stakeholders. This will offer an important opportunity for people to speak into this issue so that trust in Australia’s healthcare institutions can be re-established. As of June 2024, the Queensland gender service had 547 children receiving ‘care’. The suspension of gender therapies also comes with a pause in the intake of any new children to the programs.
Many Australians see this as a huge step forward in the gender debate, which seeks to responsibly tackle this issue and ensure that serious medical negligence does not continue to occur.
The findings of the review will certainly be a game-changer for other states, and the suspension of medication, however temporary, is already having an impact as it raises a clear red flag in the gender debate and invites a closer look into how gender dysphoria should be responsibly and logically tackled in any society that truly values the science, and the countless innocent children it directly impacts.
